Fiasp Cartridge

What is a Insulin Fiasp Cartridge?

Insulin Fiasp Cartridges contain insulin aspart, a rapid-acting type of human insulin, as well as added niacinamide and L-arginine. This improved formulation advances the onset of insulin aspartate activity, which means that it begins to work more quickly than other mealtime insulins. Insulin aspart is given to patients who do not make enough of their own insulin to properly control their blood sugar levels.

Each Fiasp Cartridge contains 3 mL of 100 units/mL solution for injection and cartons containing 5 units are available. Fiasp Cartridges are exclusively compatible with a refillable PenFill cartridge device, like the NovoPen. Fiasp is given as a subcutaneous injection into the abdomen, thigh, or upper arm.

What is it used for?

Fiasp is a rapid-acting insulin primarily used as part of Type 1 and Type 2 diabetes mellitus management. This insulin is typically paired with a longer-acting insulin, also known as a basal insulin, that works during periods between meals and during sleep. Fiasp begins to work almost immediately after administration, hence it should be given at the start, or within 20 minutes, of a meal.

Why use Fiasp Cartridges?

This preparation of insulin aspart works faster than other insulin aspart products yet has the flexibility of a wide dosing window (20 minutes), allowing for customizable dosing. Cartridges are meant for use with a refillable pen that can be easily interchanged with other compatible insulin cartridges, for patient convenience.

More information about Fisap

• Product Monograph – Health Canada
• U.S. Food and Drug Administration Medication Guide